Back to the main directory
EarningsReview / Equity
- Novo Nordisk (Buy, TP: DKK410.00) - US margins signal guidance upgrade by DnB Markets
- 1Q19 preview: Back to earth from 4Q18 high by BNP Paribas
- Repricing momentum set to continue by DnB Markets
- Solid names, demanding valuation by DnB Markets
- Q1 19 Results on 15 May by BNP Paribas
- More to go for: industry takeaways by BNP Paribas
- A first-class journey by BNP Paribas
- Nordic Semiconductor (Buy, TP: NOK52.00) - Undervalued, but Q2 a risk by DnB Markets
- Investment Daily 09/04/2019 by BNP Paribas
- Seasonal freeze set to ease by DnB Markets
- Petroleum Geo-Services (Hold, TP: NOK19.00) - Swing and a miss by DnB Markets
- Telenor (Hold, TP: NOK185.00) - Premium quality, premium price by DnB Markets
- FCMB: Strong FY 18 earnings, but weak operating efficiency; upgrade to Hold by Tellimer
- Espresso | Casino | Hold | Q1 sales preview by Kepler Cheuvreux
- Q1 19 ECB lending survey: some softening in demand by BNP Paribas
- Growth is A Rare Thing by BNP Paribas
- Industrivärden (Hold, TP: SEK205.00) - Softer portfolio view by DnB Markets
- Gudang Garam (GGRM IJ) - 2018: Net Income In Line With Street’s Expectations; Downgrade To HOLD by UOB
- Q1 19 Results on 9 May by BNP Paribas
- An excellent year for the industry, but fully priced by BNP Paribas
- Not just another driller by BNP Paribas
- Q119 sales and 15 questions for management by BNP Paribas
- Espresso | Vidrala | Buy | Q1 preview by Kepler Cheuvreux
- Crayon (Buy, TP: NOK27.00) - Expecting a solid start to 2019 by DnB Markets
- EVRY (Buy, TP: NOK40.00) - Q1 set to be another non-event by DnB Markets
- Structural buyers of equipment by BNP Paribas
- 2019e installations now at 2,000+ by DnB Markets
- Low rates and an active market support the model by BNP Paribas
- Betsson (Buy, TP: SEK90.00) - Decent Q1e in light of Sweden by DnB Markets
- Solvency, solvency, what do you really see? by BNP Paribas
- Espresso | ING Group | Buy | Not a great quarter by Kepler Cheuvreux
- Closing Apple deal, a key milestone by BNP Paribas
- LPG market turning fundamentally by DnB Markets
- TGS Nopec (Buy, TP: NOK280.00) - Cash flow the sole positive in Q1 by DnB Markets
- Espresso | Publicis Groupe | Buy | Q1 sales preview (results on 17 April after market) by Kepler Cheuvreux
- DNA (Hold, TP: EUR20.00) - A fair deal with Telenor by DnB Markets
- Golar LNG Partners (Hold, TP: USD13.50) - Sustainable DPS short-term by DnB Markets
- DTB FY 18: Upgrade to Buy on share price weakness and improved asset quality by Tellimer
- NIC Bank: FY 18 – low margins and higher operating costs hamper earnings by Tellimer
- The Supplier Myth: Why we''re still cautious by BNP Paribas
- The Alchemist: Fertilizers to spring back in 2Q? by BNP Paribas
- Danske Bank (Buy, TP: DKK165.00) - Customer retention in the spotlight by DnB Markets
- Singapore Press Holdings - 2QFY19: In line, defensive assets gaining momentum by UOB
- Rude awakening to interrupt sweet H2 dreams? by BNP Paribas
- Eyes in the skies by BNP Paribas
- Setting the bar even lower... by BNP Paribas
- FD-SOI Symposium feedback by BNP Paribas
- Investment Daily 10/04/2019 by BNP Paribas
- Atea (Sell, TP: NOK103.00) - Caution advised ahead of Q1 by DnB Markets
- Asarina Pharma (Buy, TP: SEK37.00) - All or nothing in women’s health We initiate coverage of Asarina Pharma with a BUY and SEK37 target price. The company is focused on the development of drug candidate Sepranolone to treat PMDD (in phase IIb developme by DnB Markets